Dr. Gutierrez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11800 Wilshire Blvd
Los Angeles, CA 90025
Summary
- Rodolfo Gutierrez, MD is an Oncologist based in Los Angeles, CA, specializing in Head & Neck Cancer. Dr. Gutierrez completed his medical education from the University of California, Davis, School of Medicine in 2012. He has been involved in clinical trials focusing on the safety and efficacy of IMC-C103C as both monotherapy and in combination with Atezolizumab.
Education & Training
University of California, Davis, School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab Start of enrollment: 2019 May 17
Publications & Presentations
PubMed
- 3 citationsCobimetinib Plus Vemurafenib in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez
JCO Precision Oncology. 2023-09-01
Press Mentions
Minnesota's COVID-19 Vaccine Equity Efforts to Move Beyond High-Risk AreasJune 12th, 2021- Local Non-Profit Says People Without U.S. Government Issued Identification Turned Away at Vaccination Clinics and SitesMarch 25th, 2021
- Minnesota Expands Vaccine Access to Chronically Ill, Front-Line WorkersMarch 10th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
